Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by using carbon nanotubes as a carrier molecule

Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by using carbon nanotubes as a carrier molecule

Accepted Manuscript Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by using carbon nanotubes as a carrier m...

562KB Sizes 0 Downloads 46 Views

Accepted Manuscript Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by using carbon nanotubes as a carrier molecule Lei Liu, Yu-Xin Gong, Guang-Lu Liu, Bin Zhu, Gao-Xue Wang PII:

S1050-4648(16)30386-2

DOI:

10.1016/j.fsi.2016.06.026

Reference:

YFSIM 4026

To appear in:

Fish and Shellfish Immunology

Received Date: 8 March 2016 Revised Date:

18 June 2016

Accepted Date: 21 June 2016

Please cite this article as: Liu L, Gong Y-X, Liu G-L, Zhu B, Wang G-X, Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by using carbon nanotubes as a carrier molecule, Fish and Shellfish Immunology (2016), doi: 10.1016/j.fsi.2016.06.026. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT 1

Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by

2

using carbon nanotubes as a carrier molecule

3

Lei Liua, Yu-Xin Gongb, Guang-Lu Liuc, Bin Zhua, Gao-Xue Wanga,*

a

College of Animal Science and Technology, Northwest A&F University, Xinong Road 22nd, Yangling,

6

Shaanxi 712100, China b

7

College of Veterinary Medicine, Northwest A&F University, Xinong Road 22nd, Yangling, Shaanxi

8

712100, China c

M AN U

9

SC

5

RI PT

4

College of Science, Northwest A&F University, Xinong Road 22nd, Yangling, Shaanxi 712100, China

10

* Corresponding author at: Northwest A&F University, Xinong Road 22nd, Yangling, Shaanxi 712100,

12

China. Tel./fax: +86 29 87092102.

TE D

11

13 14

EP

E-mail addresses: [email protected] (Gao-Xue Wang)

Keywords: Single-walled carbon nanotubes; Aeromonas hydrophila; DNA vaccine; immunological

16

activity

17 18

AC C

15

With the capture fishing industry declined and wild stocks diminished, the aquaculture industry has

19

become an important source of food fish [1]. However, microbial pathologies are gradually primary

20

constraints factors to hinder desirable production output. One of the major bacterial diseases is caused by

21

a Gram-negative bacterium Aeromonas hydrophila which can cause serious damage in many animals [2],

ACCEPTED MANUSCRIPT especially fish [3,4], and is also harmful to human [5]. Generally, farmers use a wide range of antibiotics

23

or chemicals to control A. hydrophila infection [6]. However, these treatments may be detrimental to

24

environment and human health [7], since they pose negative such as antibiotic resistance in environment

25

and fish [8]. Therefore, vaccines have been developed as a sustainable alternative against A. hydrophila.

26

For example, some functional or structural proteins of A. hydrophila in recombinant form have been

27

evaluated for vaccine candidates [9-13], and attempts were also made to use recombinant A. hydrophila

28

vaccine via intramuscular injection to control the bacterial spread [11,14]. Currently, one of the most

29

promising vaccine preparations against fish diseases is the DNA vaccine (delivered intramuscularly)

30

consisting of naked plasmid DNA that will result in gene expression of pathogenic proteins in the muscle

31

tissue of the vaccinated fish [15]. Although these methods have been developed for many years, there are

32

still a number of limitations, such as stress on the fish, labor costs, time required and safety issues [16].

33

Furthermore, intramuscular injection of naked DNA vaccine generally induces few and transient immune

34

protection in fish [17]. To be more effective, DNA vaccines required effective carriers to overcome these

35

obstacles.

EP

TE D

M AN U

SC

RI PT

22

In the field of carrier systems, carbon nanotubes (CNTs) are potentially useful in their development

37

for transporting and translocating bioactive molecules [18], because they can rapidly enter into

38

antigen-presenting cells and make them especially useful as carriers of antigens/DNA [19-21]. More

39

importantly, a study was found that CNTs could enhance the expression of β-galactosidase marker gene

40

5~10 times higher levels than the plasmid DNA delivered alone [22]. Recently, a novel functionalized,

41

single-walled carbon nanotubes (SWCNTs) as a vector for recombinant vaccines were found. They can

42

produce specific antibodies to resist A. hydrophila or grass carp reovirus (GCRV) infection effectively

AC C

36

ACCEPTED MANUSCRIPT 43

[23,24]. Hence, the CNTs as a vaccine carrier could be potentially used to break through the cell barrier,

44

improve vaccine and induce a protective immune response. In this study, CNTs-aerA (a virulence factor that has hemolytic and cytolytic properties) vaccine was

46

prepared to enhance the efficacy of an aerA DNA vaccine against A. hydrophila in grass carp. We

47

evaluated the immune efficacy of CNTs-aerA DNA vaccine in vaccinating fish after intramuscular

48

injection. This study will provide a further information for future work on a wide range of CNTs-DNA

49

vaccine delivery systems in fish.

SC

RI PT

45

Grass carp with the total length and body weight of 3.0 ± 0.5 cm and 1.0 ± 0.1 g (mean values ± SD)

51

were kindly provided by the Xinmin Aquatic Breeding Center (Heyang, Shaanxi, China) and acclimatized

52

in the laboratory for two weeks before experimental manipulation. Fish were reared daily with a diet of

53

commercial dry pellets (Tianlong Feed Company, China) and held in 300 L aquaria at 28°C aerated fresh

54

water under laboratory conditions for two weeks, in which approximately 25% of the water was replaced

55

daily. According to the study of Vazquez-Juarez et al. [25], a PCR technique was used to confirm free

56

from A. hydrophila in fish. All protocols strictly adhered to the guide for care and use of laboratory

57

animals, and were approved by Northwest A&F University animal protection committee.

TE D

EP

A. hydrophila strain XS91-4-1 used in this experiment was preserved in our laboratory with 20%

AC C

58

M AN U

50

59

glycerol at -80°C. During the experimental period, A. hydrophila was inoculated into liquid LB medium

60

and grown overnight with constant shaking. Additionally, Escherichia coli DH5α (CWBIO, Beijing,

61

China) was also cultured in LB medium.

62 63

Cloning of aerA gene of A. hydrophila strain XS91-4-1 were performed according to our previous study

[24].

Two

oligonucleotide

primers

(F:

5'-GCAGAGCCCGTCTATCCAGA-3';

R:

ACCEPTED MANUSCRIPT 5'-TCACTCCAGCCTCAGGCCTTG-3') consists of Xho I and BamH I restriction enzyme sites,

65

respectively. After aerA gene were ligated with pMD19T vector (Takara, Dalian, China), transformed into

66

competent E. coli DH5α cells (CWBIO, Beijing, China) and sequenced by Sangon Biological Company

67

(Shanghai, China), the aerA gene excised from pMD19T-aerA by digestion with Xho I/BamH I restricion

68

enzyme (Takara, Dalian, China) was inserted into the pEGFP (Invitrogen, Carlsbad, CA, USA) to

69

generate pEGFP-aerA. A recombinant plasmid pEGFP-aerA containing the capsid open reading frame

70

was transformed into E. coli DH5a cells (CWBIO, Beijing, China) and the recombinant constructs were

71

sequenced by Sangon Biological Company (Shanghai, China). The positive clone was grown in LB broth

72

with ampicillin and incubated at 37

73

with the Endo-free Plasmid Mini Kit (Omega, USA) following the manufacturer's instructions and the

74

concentration was measured by the NanoDrop spectrophotometer (ND-1000, NanoDrop Technologies

75

Inc., Wilmington, DE) and conserved at -20

M AN U

SC

RI PT

64

overnight with shaking. Recombinant plasmid DNA was isolated

TE D

.

The raw SWCNTs were purchased from Chengdu Organic Chemicals Co., Ltd. Chinese Academy of

77

Sciences (Chengdu, China). Preparation of SWCNTs-pEGFP-aerA vaccine was performed as described

78

previously [23].

For vaccination experiments, healthy grass carp were distributed randomly into eight groups

AC C

79

EP

76

80

(containing six treatment groups and two control groups, 80 fish per group). The experimental fish were

81

injected intramuscularly with 0.1 mL pEGFP-aerA/SWCNTs-pEGFP-aerA (dissolve in PBS, pH = 7.4) in

82

three different doses (1, 5 and 10 µg) in the right, dorsal, epaxial muscle in front of the dorsal fin after

83

being anaesthetized with 20.0 g/m3 MS-222 [6]. The control groups were injected intramuscularly with 10

84

µg of pEGFP diluted in 0.1 mL PBS or 0.1 mL of PBS alone. Subsequently, control and vaccinated

ACCEPTED MANUSCRIPT 85

groups were transferred to different tanks during the whole immunization period (6 weeks). Antiserum preparation and measurement of anti-aerA antibody responses were made by

87

enzyme-linked immunosorbent assay (ELISA) according to the previous study [26], and rabbit sera

88

anti-IgM was prepared following the method of Ding et al. [27]. For analyses of the presence of specific,

89

neutralizing antibodies, vaccinated and control fish were sampled weekly until 6 weeks for antibody

90

determination. At each time points, five samples from each control and vaccinated groups were pooled

91

and prepared according the previous method [24]. Rabbit anti-IgM polyclonal antibody was used as

92

primary antibody, and HRP-conjugated goat anti-rabbit IgG (CWBIO, Beijing, China) was used as

93

secondary antibody. The primary and secondary antibodies were diluted 1:1000 immediately before use

94

with PBS containing 3% skimmed milk. Additionally, DAB horseradish peroxidase color development kit

95

(Tiangen Biotech, Beijing, China) was used for color development. The plate was read at 450 nm with a

96

precision microplate reader (Molecular Devices Corp., Palo Alto, CA).

TE D

M AN U

SC

RI PT

86

After 21 d, 15 sampled fish from each control and vaccinated groups were euthanized through

98

washrag soaked with 20.0 g/m3 MS-222 and dissected immediately with sterile scissors. The kidney was

99

removed, where five fish from one pool per condition were sampled for analyzing gene expression and

100

this experiment was performed in triplicate replicates. Pooled kidney tissue samples were taken from the

101

fish and immediately frozen in liquid nitrogen for subsequent RNA isolation. Total RNA was extracted

102

using TRIZOL reagent (CWBIO, Beijing, China) following manufacturer’s instruction. The isolated RNA

103

samples were diluted in RNase-free double distilled water and treated with DNase I (Takara, Dalian,

104

China) according to the manufacturer’s instructions. RNA was reverse transcribed using PrimeScript RT

105

reagent Kit (Perfect Real Time) and oligo d (T) primer (Vazyme, USA). Real-time PCR (RT-PCR) was

AC C

EP

97

ACCEPTED MANUSCRIPT performed using CFX96 Real-Time PCR Detection System (Bio-Rad, USA) and AceQ® qPCR SYBR®

107

Green Master Mix (Vazyme, USA), with 18S RNA as the endogenous control [28]. The primers of seven

108

immune-relevant genes were designed by other studies [26] and are listed in Table 1. The relative

109

quantification of gene transcription was performed as described in the previous study [6]. Each individual

110

sample was run in triplicate wells. Relative mRNA expression was calculated using 2-△△Ct method with

111

the formula, F = 2-△△Ct, △△Ct = (Ct, target gene – Ct, reference gene) – (Ct, target gene – Ct, reference gene)control [29].

112

Table 1

SC

RI PT

106

At the time point of 21 days post-vaccination, each group was randomly chosen 30 fish to transfer to

114

different tanks. Then fish were challenged by intraperitoneal injection with 30 µL culture suspension of A.

115

hydrophila (5.0 × 106 CFU/mL of fish). Mortality rates were recorded daily, and dead fish were removed

116

from the tank daily. The relative percent survival (RPS) was calculated according to Amend's method

117

[30].

TE D

M AN U

113

Data were presented as mean ± standard deviation (SD). Differences between experimental group

119

and control were generated with SPSS (version 18.0) statistical software (SPSS Inc., Chicago, IL, USA)

120

using ANOVA followed by Tukey’s post hoc tests using SPSS 18.0. A P value of <0.05 or <0.01 was

121

considered statistically significant.

AC C

122

EP

118

The amplification of the aerA gene (expected size 1332 bp) of A. hydrophila was shown in Fig. 1A.

123

When the aerA gene was cloned into the cloning vector pMD19T and eukaryotic expression plasmid

124

pEGFP, it was confirmed by restriction enzyme digestion (Fig. 1B and C) and sequence analysis (data not

125

show). Both results confirmed that recombinant plasmid was successfully constructed.

126

[Fig. 1]

ACCEPTED MANUSCRIPT To compare the humoral immune response, we evaluated the neutralizing activity of sera samples

128

obtained from vaccinated fish during 1-6 weeks post-initiation vaccination. ELISA analysis showed that

129

the antibody levels increased with the increasing doses of pEGFP-aerA or SWCNTs-pEGFP-aerA (Fig. 2).

130

The highest levels of specific antibodies were observed at 4 weeks post vaccination in 10 µg pEGFP-aerA

131

or SWCNTs-pEGFP-aerA groups. Generally, SWCNTs-pEGFP-aerA elicited higher levels of antibody

132

compared with free pEGFP-aerA at the same immunization dose. Meanwhile, no significant difference

133

was found in the fish injected with PBS and pEGFP.

134

SC

RI PT

127

M AN U

[Fig. 2]

As shown in Fig. 3, both aerA and SWCNTs-aerA in highest immunization dose induced a

136

significant enhancement of all immune-related genes (type I interferon (IFN-I), tumor necrosis factor α

137

(TNFα), C-reactive protein (CRP), interleukin 8 (IL-8), immunoglobulin M (IgM), major

138

histocompatibility complex (MHC) class I and Cluster of differentiation 8α (CD8α)) expression in the

139

kidney. Furthermore, all these genes expression were induced by 10 µg SWCNTs-pEGFP-aerA to

140

increase

141

SWCNTs-pEGFP-aerA treatments were significantly higher than that in the pEGFP-aerA groups.

143

inductions observed.

EP

than 3-fold

AC C

142

greater

TE D

135

And

the

relative

expression levels in

[Fig.3]

Grass carp were challenged by injected intramuscularly with 5.0 × 106 CFU/mL of A. hydrophila.

144

The result in Fig. 4 showed that the cumulative mortality of treatment and control groups after being

145

challenged with a lethal dose of A. hydrophila at 21 days post vaccination. For two control groups (PBS

146

and pEGFP) and two vaccinated groups (1 and 5 µg pEGFP-aerA), the mortalities were occurred at 3-day

147

after challenge and after 8-day, the cumulative mortality of two control groups was reached to 100%. For

ACCEPTED MANUSCRIPT SWCNTs-pEGFP-aerA vaccinated groups (1, 5 and 10 µg), the cumulative mortalities were reached to

149

42.7%, 30.4% and 16.3%, respectively, and comparably, a lower immune protective effects were obtained

150

in pEGFP-aerA vaccinated groups (1, 5 and 10 µg) (Table 2).

151

[Fig. 4]

152

[Table 2]

RI PT

148

In the past decade, DNA vaccine has been extensively applied for the prevention of aquaculture

154

diseases caused by different pathogens, especially infectious virus [31-33]. Compared with live,

155

attenuated vaccines, inactivated vaccines, and purified subunits of the pathogen, DNA vaccine has the

156

advantage of being inexpensive, safe, stable, and inducing both humoral and cellular immunities [34,35].

157

Immunization with antigen-encoding plasmid DNA can produce the target protein in vivo upon

158

introduction to the host, thereby eliciting powerful and long-lasting cellular and humoral immune

159

responses that is similar to that induced by natural infection with intracellular pathogens [36]. However,

160

the rapid tissue clearance and on-site degradation of DNA of conventional DNA vaccination may reduce

161

pDNA uptake and transgene expression [37,38]. To enhance the efficacy of DNA vaccines, in this study,

162

SWCNTs vaccine delivery system was used to deliver pEGFP-aerA DNA vaccine against A. hydrophila.

163

Our previous study have found that higher levels of transcription and expression of the vp7 gene of

164

GCRV could be detected in muscle tissues of grass carp 28 days post-injection in SWCNTs-pcDNA-vp7

165

treatment groups comparing with naked pcDNA-vp7 treatment groups [23]. In addition, the potency of

166

ammonium group-functionalized multi-walled carbon nanotubes (MWCNTs) could enhance the

167

transfection and expression efficiency of plasmid DNA (pEGFP-vp5) in Ctenopharyngodon idellus

168

kidney (CIK) cells [39]. SWCNTs was also found to facilitate higher pDNA uptake and gene expression

AC C

EP

TE D

M AN U

SC

153

ACCEPTED MANUSCRIPT than pDNA alone in Chinese hamster ovary cells [40]. In the challenge test, the result reflected that

170

pEGFP-aerA DNA vaccine could protect grass carp against A. hydrophila infection, with a lower

171

percentage of mortality rates in 15 days. Further, SWCNTs- pEGFP-aerA DNA vaccine showed a better

172

protection efficacy on grass carp than pEGFP-aerA, and naked plasmid vaccine did not enhance innate

173

antibacterial immunity of fish as the control group. These results were in agreement with the previous

174

findings that SWCNTs can improve the plasmid/antigen stability, and prolong the time of plasmid/antigen

175

degradation [23].

SC

RI PT

169

In the past, most research about DNA vaccines against bacterial pathogens in aquaculture have been

177

reported, and these vaccine were demonstrated to be effective against challenges of the respective

178

pathogens [41-44]. In our tests, the levels of specific antibody increased significantly and persisted up to

179

6 weeks of post immunization. It might be that the SWCNTs-pEGFP-aerA could be delivered into the fish

180

cells, and the plasmid DNA was released from the nanotubes, and thus expressed antigen. With the

181

increase of amounts of plasmid DNA released from SWCNTs, more antigens were expressed and stronger

182

immune response was induced.

EP

TE D

M AN U

176

In the present study, we compared the expressions of immune-related genes of free pEGFP-aerA and

184

SWCNTs-pEGFP-aerA DNA vaccine on grass carp via intramuscular injection immunization. The results

185

indicated that fish immunization with SWCNTs-pEGFP-aerA DNA vaccine augmented the production of

186

specific antibodies and exhibited a high level of survival rate compared with pEGFP-aerA alone. Herein,

187

consistent with the production of specific antibodies (Fig. 2), the IgM expression was increased

188

significantly in vaccinated fish kidney. It is known that IgM is a major component of the humoral immune

189

system of teleost fish, regarded as the first antibody [45,46]. Some investigators have reported that the

AC C

183

ACCEPTED MANUSCRIPT IgM expression would be intensively increase in many tissues and organs from the second week after

191

immunization and maintained almost one month [47]. Besides, IL-8, IFN-I and TNFα, an important

192

component in innate immunity and the inflammatory, were also found up-regulated by the DNA vaccine

193

treatment in this study. These genes were considered to be an important component in innate immunity

194

and antivirus response in fish [48-50], and especially TNFα is considered as an important

195

pro-inflammatory factors to induce the inflammatory response by regulating the expression of other

196

cytokines [51]. Thus, the risen gene levels may reflect the initiation of specific adaptive immune

197

responses [52]. Additionally, CRP levels were observed to increase in grass carp vaccinated with

198

pEGFP-aerA/SWCNTs-pEGFP-aerA DNA vaccines, while CRP usually served as the major acute phase

199

reactant and played an important role in the innate immune response to an inflammatory stimulus in fish

200

[53]. Since MHC I are involved in offering antigenic peptides for recognition by the TCR/CD8 complex

201

of cytotoxic T lymphocytes and CD8 molecules acts as a coreceptor and lies in its active role in activating

202

T cells [6,54,55], their up-regulation indicated that the protective effect of the DNA vaccines might be

203

due to the induction of humoral and cellular immune response.

EP

TE D

M AN U

SC

RI PT

190

Currently, it is an important consideration on safety in preparing the vaccine on fish. Even though a

205

series of researches have assessed toxicity of raw carbon nanotubes in mice, no significant effect was

206

found in cell culture experiments [56]. For fish embryos and larvae, Zhu et al. found that a series of

207

tested index were significantly changed when the concentration of SWCNTs was above 50 mg/L by bath

208

exposure [57]. However, there was no report about the toxicity of CNTs in fish by intramuscular injection,

209

and the information was lack in relative action mechanisms. Therefore, toxicity assessment on aquatic

210

animals of SWCNTs is also needed to make further studies.

AC C

204

ACCEPTED MANUSCRIPT In conclusion, our results showed that SWCNTs loaded with DNA vaccine induced a better

212

protection to juvenile grass carp against A. hydrophlia. Moreover, SWCNTs conjugated with DNA

213

vaccine provided significantly protective immunity compared with free DNA vaccine. Thereby, SWCNTs

214

may be considered as a potential efficient DNA vaccine carrier to enhance the immunological activity.

216

This work was supported by the Scientific Innovation and Achievements Transformation Fund for Northwest A&F University (XNY2013-25).

SC

215

RI PT

211

AC C

EP

TE D

M AN U

217

ACCEPTED MANUSCRIPT 218

Reference

219

[1] Plant KP, Lapatra SE. Advances in fish vaccine delivery. Dev Comp Immunol. 2011 35:1256–62.

220

[2] Huang L, Qin Y, Yan Q, Lin G, Huang L, Huang B, Huang W. MinD plays an important role in Aeromonas hydrophila adherence to Anguilla japonica mucus. Gene. 2015 565:275–81.

RI PT

221

[3] Sahoo P, Das Mahapatra K, Saha J, Barat A, Sahoo M, Mohanty B, Sahoo M, Mohanty BR, Gjerde B,

223

Odegård J, Rye M, Salte R. Family association between immune parameters and resistance to

224

Aeromonas hydrophila infection in the Indian major carp, Labeo rohita, Fish Shellfish Immunol. 2008

225

25:163–9.

M AN U

SC

222

226

[4] Mu X, Pridgeon JW, Klesius PH. Comparative transcriptional analysis reveals distinct expression

227

patterns of channel catfish genes after the first infection and re-infection with Aeromonas hydrophila,

228

Fish Shellfish Immunol. 2013 35:1566–76.

230

[5] Kregiel D, Niedzielska K. Effect of plasma processing and organosilane modifications of polyethylene

TE D

229

on Aeromonas hydrophila biofilm formation. BioMed Res Int. 2014 (8 pages). [6] Liu L, Gong YX, Zhu B, Liu GL, Wang GX, Ling F. Effect of a new recombinant Aeromonas

232

hydrophila vaccine on the grass carp intestinal microbiota and correlations with immunological

233

responses. Fish Shellfish Immunol. 2015 45:175–83.

235 236 237 238

AC C

234

EP

231

[7] Cao H, He S, Wang H, Hou S, Lu L, Yang X. Bdellovibrios, potential biocontrol bacteria against pathogenic Aeromonas hydrophila. Vet Microbiol. 2012 154:413–8. [8] Cabello FC. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol. 2006 8:1137–44. [9] Fang HM, Ge R, Sin YM. Cloning, characterization and expression of Aeromonas hydrophila major

ACCEPTED MANUSCRIPT 239 240 241

adhesin. Fish Shellfish Immunol. 2004 16:645–58. [10] Khushiramani R, Girisha SK, Karunasagar I, Karunasagar I. Protective efficacy of recombinant OmpTS protein of Aeromonas hydrophila in Indian major carp. Vaccine. 2007 25:1157–8. [11] Guan R, Xiong J, Huang W, Guo S. Enhancement of protective immunity in European eel (Anguilla

243

anguilla) against Aeromonas hydrophila and Aeromonas sobria by a recombinant Aeromonas outer

244

membrane protein. Acta Biochim Biophys Sin. 2011 43:79–88.

247 248

SC

246

[12] Poobalane S, Thompson KD, Ardó L, Verjan N, Han HJ, Jeney G, et al. Production and efficacy of an Aeromonas hydrophila recombinant S-layer protein vaccine for fish. Vaccine. 2010 28:3540–7.

M AN U

245

RI PT

242

[13] Yeh HY, Klesius PH. Over-expression, purification and immune responses to Aeromonas hydrophila AL09-73 flagellar proteins. Fish Shellfish Immunol. 2011 31:1278–83.

[14] Khushiramani RM, Maiti B, Shekar M, Girisha SK, Akash N, Deepanjali A, et al. Recombinant

250

Aeromonas hydrophila outer membrane protein 48 (Omp48) induces a protective immune response

251

against Aeromonas hydrophila and Edwardsiella tarda. Res Microbiol. 2012 163:286–91.

253

[15] Evensen Ø, Leong JAC. DNA vaccines against viral diseases of farmed fish. Fish Shellfish Immunol.

EP

252

TE D

249

2013 6:1751–8.

[16] Nakanishi T, Kiryu I, Ototake M. Development of a new vaccine delivery method for fish:

255

percutaneous administration by immersion with application of a multiple puncture instrument.

256

Vaccine. 2002 20:3764–9.

257 258 259

AC C

254

[17] Garver K, Conway C, Elliott D, Kurath G. Analysis of DNA-vaccinated fish reveals viral antigen in muscle, kidney and thymus, and transient histopathologic changes. J Mar Biotechnol. 2005 7:540–53. [18] Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon

ACCEPTED MANUSCRIPT 260

nanotubes. Chem Commun–Camb. 2005 7:571–7. [19] Yandar N, Pastorin G, Prato M, Bianco A, Patarroyo ME, Lozano JM. Immunological profile of a

262

Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium

263

berghei mouse model. Vaccine. 2008 26:5864–73.

RI PT

261

[20] Parra J, Abad-Somovilla A, Mercader JV, Taton TA, Abad-Fuentes A. Carbon nanotube-protein

265

carriers enhance size-dependent self-adjuvant antibody response to haptens. J Control Release. 2013

266

170:242–51.

SC

264

[21] Villa CH, Dao T, Ahearn I, Fehrenbacher N, Casey E, Rey DA, et al. Single-walled carbon nanotubes

268

deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens.

269

ACS Nano. 2011 5:5300–11.

271

[22] Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res. 2008 41:60–8.

TE D

270

M AN U

267

[23] Zhu B, Liu GL, Gong YX, Ling F, Wang GX. Protective immunity of grass carp immunized with

273

DNA vaccine encoding the vp7 gene of grass carp reovirus using carbon nanotubes as a carrier

274

molecule. Fish Shellfish Immunol. 2015 42:325–34.

EP

272

[24] Gong YX, Zhu B, Liu GL, Liu L, Ling F, Wang GX, Xu XG. Single-walled carbon nanotubes as

276

delivery vehicles enhance the immunoprotective effects of a recombinant vaccine against Aeromonas

277

hydrophila. Fish Shellfish Immunol. 2014 42:213–20.

AC C

275

278

[25] Vázquez-Juárez RC, Barrera-Saldaña HA, Hernández-Saavedra NY, Gómez-Chiarri M, Ascencio F.

279

Molecular cloning, sequencing and characterization of omp48, the gene encoding for an antigenic

280

outer membrane protein from Aeromonas veronii. J Appl Microbiol. 2003 94:908–18.

ACCEPTED MANUSCRIPT 281

[26] Zhu B, Liu GL, Gong YX, Ling F, Song LS, Wang GX. Single-walled carbon nanotubes as candidate

282

recombinant subunit vaccine carrier for immunization of grass carp against grass carp reovirus. Fish

283

Shellfish Immunol. 2014 279–93.

285

[27] Ding WD, Cao LP, Cao ZM. Purification of serum IgM from grass carp (Ctenopharyngodon idellus)

RI PT

284

and preparation of rabbit sera anti-IgM. Acta Hydrobiol Sin. 2010 34:164–9.

[28] Su J, Zhang R, Dong J, Yang C. Evaluation of internal control genes for qRT-PCR normalization in

287

tissues and cell culture for antiviral studies of grass carp (Ctenopharyngodon idella). Fish Shellfish

288

Immunol. 2011 30:830–5.

291 292

M AN U

290

[29] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−∆∆CT method. Methods. 2001 25:402–8.

[30] Amend DF. Potency testing of fish vaccines. International symposium on fish biologics: serodiagnostics and vaccines. Dev Biol Stand. 1981 49:447–54.

TE D

289

SC

286

[31] Garver KA, Lapatra SE, Gael K. Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA

294

vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon. Dis Aquat Organ. 2005

295

64:13–22.

EP

293

[32] Lorenzen N, Lorenzen E, Einer-Jensen K, Heppell J, Wu T, Davis H. Protective immunity to VHS in

297

rainbow trout (Oncorhynchus mykiss, Walbaum) following DNA vaccination. Fish Shellfish Immunol.

298

1998 8:261–70.

AC C

296

299

[33] Takano T, Iwahori A, Hirono I, Aoki T. Development of a DNA vaccine against hirame rhabdovirus

300

and analysis of the expression of immune-related genes after vaccination. Fish Shellfish Immunol.

301

2004 17:367–74.

ACCEPTED MANUSCRIPT

304 305 306 307

2000 43:29–43. [35] Tonheim TC, Bogwald J, Dalmo RA. What happens to the DNA vaccine in fish? A review of current knowledge. Fish Shellfish Immunol. 2008 25:1–18.

RI PT

303

[34] Heppell J, Davis HL. Application of DNA vaccine technology to aquaculture. Adv Drug Deliv Rev.

[36] Chen ZY, Lei XY, Zhang QY. The antiviral defense mechanisms in mandarin fish induced by DNA vaccination against a rhabdovirus. Vet Microbiol. 2012 157:264–75.

SC

302

[37] Hølvold LB, Fredriksen BN, Bøgwald J, Dalmo RA. Transgene and immune gene expression

309

following intramuscular injection of Atlantic salmon (Salmo salar L.) with DNA-releasing PLGA

310

nano- and microparticles. Fish Shellfish Immunol. 2013 35:890–9.

M AN U

308

[38] Tom Christian T, Roy Ambli D, Jarl BG, Tore S. Specific uptake of plasmid DNA without reporter

312

gene expression in Atlantic salmon (Salmo salar L.) kidney after intramuscular administration. Fish

313

Shellfish Immunol. 2008 24:90–101.

TE D

311

[39] Liu GL, Wang Y, Hu Y, Yu X, Zhu B, Wang GX. Functionalized multi-wall carbon nanotubes

315

enhance transfection and expression efficiency of plasmid DNA in fish cells. Int J Mol Sci. 2016 17:

316

doi, 10.3390/ijms17030335.

318

[40] Davide P, Ravi S, David MC, Mathieu E, Jean-Paul B, Maurizio P, et al. Functionalized carbon

AC C

317

EP

314

nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed. 2004 43:5242–6.

319

[41] Kumar SR, Parameswaran V, Ahmed VP, Musthaq SS, Hameed AS. Protective efficiency of DNA

320

vaccination in Asian seabass (Lates calcarifer) against Vibrio anguillarum. Fish Shellfish Immunol.

321

2007 23:316–26.

322

[42] Pasnik DJ, Smith SA. Immunogenic and protective effects of a DNA vaccine for Mycobacterium

ACCEPTED MANUSCRIPT 323

marinum in fish. Vet Immun Immunopathol. 2005 103:195–206. [43] Pasnik DJ, Smith SA. Immune and histopathologic responses of DNA-vaccinated hybrid striped bass

325

Morone saxatilis × M. chrysops after acute Mycobacterium marinum infection. Dis Aquat Organ.

326

2006 73:33–41.

RI PT

324

[44] Rajesh Kumar S, Ishaq Ahmed VP, Parameswaran V, Sudhakaran R, Sarath Babu V, Sahul Hameed

328

AS. Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in Asian sea bass (Lates

329

calcarifer) to protect from Vibrio (Listonella) anguillarum. Fish Shellfish Immunol. 2008 25:47–56.

330

[45] Lorenzen N, Lapatra SE. Immunity to rhabdoviruses in rainbow trout: the antibody response. Fish

332 333

Shellfish Immunol. 1999 9:345–60.

M AN U

331

SC

327

[46] Reddy PS, Corley RB. The contribution of ER quality control to the biologic functions of secretory IgM. Immunol Today. 1999 20:582–8.

[47] Cui M, Zhang Q, Yao Z, Zhang Z, Zhang H, Wang Y. Immunoglobulin M gene expression analysis

335

of orange-spotted grouper, Epinephelus coioides, following heat shock and Vibrio alginolyticus

336

challenge. Fish Shellfish Immunol. 2010 29:1060–5.

339 340 341 342 343

EP

338

[48] Secombes C, Wang T, Hong S, Peddie S, Crampe M, Laing K, et al. Cytokines and innate immunity of fish. Dev Comp Immunol. 2001 25:713–23.

AC C

337

TE D

334

[49] Colonna M, Krug A, Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr Opin Immunol. 2002 14:373–9. [50] Baldwin ET, Weber IT, Charles RS, Xuan J, Appella E, Yamanda M, et al. Crystal structure of interleukin-8: symbiosis of NMR and crystallography. Proc Natl Acad Sci. 1991 88:502–6. [51] Dan XM, Zhang TW, Li YW, Li AX. Immune responses and immune-related gene expression profile

ACCEPTED MANUSCRIPT 344

in orange-spotted grouper after immunization with Cryptocaryon irritans vaccine. Fish Shellfish

345

Immunol. 2013 34:885–91.

347

[52] Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. Nat Med. 2005 11:S63–S8.

RI PT

346

[53] Maccarthy E, Burns I, Irnazarow I, Polwart A, Tj, Shrive A, Hoole D. Serum CRP-like protein

349

profile in common carp Cyprinus carpio challenged with Aeromonas hydrophila and Escherichia coli

350

lipopolysaccharide. Dev Comp Immunol. 2008 32:1281–9.

355 356 357 358 359

M AN U

354

[55] Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994 76:287–99.

[56] Liu Z, Tabakman S, Welsher K, Dai H. Carbon nanotubes in biology and medicine: in vitro and in

TE D

353

Immunol. 19897:601–24.

vivo detection, imaging and drug delivery. Nano Res. 2009 2:85–120. [57] Zhu B, Liu G L, Ling F, Song LS, Wang GX. Development toxicity of functionalized single-walled

EP

352

[54] Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev

carbon nanotubes on rare minnow embryos and larvae. Nanotoxicology, 2014 9:1–12.

AC C

351

SC

348

ACCEPTED MANUSCRIPT Figure captions

361

Fig. 1. Analysis of aerA expression. (A) RT-PCR amplification of aerA: lane M, DNA marker; lane 1,

362

aerA. (B) analysis of recombinant plasmid: lane M, DNA marker; lane 1, double enzymes digested

363

pMD19T-aerA with Xho I and BamH I; lane 2, pMD19T-aerA. (C) analysis of recombinant plasmid: lane

364

M, DNA marker; lane 1, pEGFP-aerA; lane 2, double enzymes digested pEGFP-aerA with Xho I and

365

BamH I.

366

Fig. 2. Specific antibody levels of fish vaccinated with DNA vaccine were determined by ELISA. Data

367

are means for three assays and presented as the means ± SE. **P < 0.01; *P < 0.05.

368

Fig. 3. Real-time PCR analysis of the expression of immune-related genes in fish vaccinated with

369

different vaccine formulations after 21 d. (A) IL-8; (B) IFN-I; (C) TNFa; (D) CRP; (E) MHC-I; (F) IgM;

370

(G) CD8α. Data are means for three assays and presented as the means ± SE. **P < 0.01; *P < 0.05.

371

Fig. 4. Cumulative mortalities of vaccinated fish. The accumulated mortalities were calculated at the end

372

of the monitored period.

AC C

EP

TE D

M AN U

SC

RI PT

360

ACCEPTED MANUSCRIPT Table 1 Sequences of primer pairs used for the analysis of mRNA expression by qRT-PCR.

Product size (bp)

GenBank accession no.

Forward

ATTTCCGACACGGAGAGG

90

EU047719

Reverse

CATGGGTTTAGGATACGCTC

Forward

GGTGAAGTTTCTTGCCCTGACCTTAG

173

AB196166

Reverse

CCTTATGTGATGGCTGGTATCGGG

TNF-α

Forward

TGTGCCGCCGCTGTCTGCTTCACGCT

291

EU047718

Reverse

GATGAGGAAAGACACCTGGCTGTAGA

CRP

Forward

CTGCCTCCGCTCTCCATCTT

300

FJ547474

Reverse

TCCCTTTGGCACATACGGTTCCTGA

IL-8

Forward

AGGTCTGGGTGTAGATCCACGCTG

Reverse

TTAGTGTGAAAACTAACATGATCTCT

IgM

Forward

GCTGAGGCATCGGAGGCACAT

MHC-I

Reverse

TTGGGTCTCGCACCATTTTCTC

Forward

CCTGGCAGAAAAATGGACAAG

Reverse

CCAACAACACCAATGACAATC

Forward

GAGTCTCTGCACGGATCTAT

Reverse

GTGTAGTGTTCCGAATTTAAGT

AC C

EP

TE D

CD8α

SC

IGF-I

137

EU047717

170

DQ417927

M AN U

18S

RI PT

Primer sequences (from 5' to 3')

Genes

271

AY391782

172

GQ355586

ACCEPTED MANUSCRIPT Table 2 Corresponding RPS values of vaccinated and control fish. Cumulative percentage mortality (%) and calculated relative percentage survival (RPS) following challenge with A. hydrophila in experimental

Fish injected with

Cumulative mortality (21 d)

PBS

100.0%

pEGFP 10 µg

100.0%

pEGFP-aerA 1 µg

92.1%

pEGFP-aerA 5 µg

70.7%

pEGFP-aerA 10 µg

54.9%

SWCNTs-pEGFP-aerA 1 µg

42.7%

EP AC C



SC

7.9%

29.3%

45.1%

57.3%

30.4%

69.6%

16.3%

83.7%

TE D

SWCNTs-pEGFP-aerA 10 µg

RPS (21 d)



M AN U

SWCNTs-pEGFP-aerA 5 µg

RI PT

groups of DNA vaccinated fish by intramuscular injection.

ACCEPTED MANUSCRIPT

M

1

B

M

1

2

M

1

2

AC C

EP

TE D

C

M AN U

SC

RI PT

A

Fig. 1.

ACCEPTED MANUSCRIPT

0.7

**

PBS

**

**

** **

**

0.5 0.4

**

**

0.3

** **

**** **

** **

**

** ** ** **

**

**

** **

**

**

** **

pEGFP-aerA 1 µg pEGFP-aerA 5 µg pEGFP-aerA 10 µg SWCNTs-pEGFP-aerA 1 µg

*

*

SWCNTs-pEGFP-aerA 5 µg

0.2

RI PT

Absorbance (OD450)

**

0.6

SWCNTs-pEGFP-aerA 10 µg

0.1

pEGFP

0 1

2

3

4

6

SC

Weeks post-vaccination

5

AC C

EP

TE D

M AN U

Fig. 2.

ACCEPTED MANUSCRIPT A

4

pEGFP-aerA

IL-8

**

Fold change

SWCNTs-pEGFP-aerA

3

** *

2

RI PT

1 0 PBS

pEGFP

*

*

1

5

10

Fold change

4

pEGFP-aerA

IFN-I

SWCNTs-pEGFP-aerA

3

**

2

TE D pEGFP

EP

PBS

pEGFP-aerA

AC C

5 4

**

*

0

Fold change

**

**

1

C

M AN U

5

B

SC

Injected dose (µg)

1

5

10

Injected dose (µg)

TNFα

**

**

SWCNTs-pEGFP-aerA

**

3

**

*

2 1 0

PBS

pEGFP

1

5 Injected dose (µg)

10

ACCEPTED MANUSCRIPT 6

Fold change

5

pEGFP-aerA

CRP

**

SWCNTs-pEGFP-aerA

**

4 3

**

*

2

RI PT

D

1 0 PBS

pEGFP

1

5

10

pEGFP-aerA

MHC-I

Fold change

SWCNTs-pEGFP-aerA

6 4

**

**

12

pEGFP

EP

PBS

TE D

0

AC C

pEGFP-aerA

1

**

**

**

2

F

M AN U

8

E

SC

Injected dose (µg)

5

10

Injected dose (µg)

IgM

**

Fold change

SWCNTs-pEGFP-aerA

9

**

6

**

** **

3 0 PBS

pEGFP

1

5 Injected dose (µg)

10

ACCEPTED MANUSCRIPT 5

Fold change

4

pEGFP-aerA

CD8α

**

SWCNTs-pEGFP-aerA

**

3

**

**

2 1 0 PBS

pEGFP

1

RI PT

G

5

SC

Injected dose (µg)

AC C

EP

TE D

M AN U

Fig. 3.

10

100 90 80 70 60 50 40 30 20 10 0

PBS pEGFP 10 µg pEGFP-ae rA 1 µg pEGFP-ae rA 5 µg pEGFP-ae rA 10 µg SWC NTs-pEGFP-ae rA 1 µg SWC NTs-pEGFP-ae rA 5 µg SWC NTs-pEGFP-ae rA 10 µg

3

6

9

12

Days after challenge

18

21

AC C

EP

TE D

M AN U

SC

Fig. 4.

15

RI PT

Cumulative mortality (%)aaa

ACCEPTED MANUSCRIPT

ACCEPTED MANUSCRIPT Highlights: 1. SWCNTs can be used as carriers for DNA vaccine. 2. SWCNTs-DNA vaccine enhanced the immunological activity.

AC C

EP

TE D

M AN U

SC

RI PT

3. SWCNTs-DNA vaccine induced a better protection to grass carp against A. hydrophlia.